Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Chronic Renal Failure

  Free Subscription


4 Am J Nephrol
3 J Nephrol
1 Kidney Int
1 Lancet
2 N Engl J Med
4 Nephrol Dial Transplant
2 Pediatr Nephrol
1 PLoS One
1 Semin Dial
1 Transplant Proc

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Nephrol

  1. SERRANO M, Srivastava A, Buck G, Zhu B, et al
    Dietary Protein and Fiber Affect Gut Microbiome and Treg/Th17 Commitment in Chronic Kidney Disease Mice.
    Am J Nephrol. 2022 Nov 7:1-6. doi: 10.1159/000526957.
    PubMed         Abstract available

  2. TANGRI N, Mathur V, Reaven N, Funk SE, et al
    Relationship between Metabolic Acidosis and Chronic Kidney Disease Progression across Racial and Ethnic Groups: An Observational, Retrospective Cohort Study.
    Am J Nephrol. 2022 Nov 8:1-11. doi: 10.1159/000527036.
    PubMed         Abstract available

  3. QU X, Tong X, Hou X, Zhang J, et al
    Trends in Adherence to Recommended Physical Activity and Its Association with Mortality and Disease Progression among US Adults with Chronic Kidney Disease.
    Am J Nephrol. 2022 Nov 7:1-12. doi: 10.1159/000526956.
    PubMed         Abstract available

  4. ALLINOVI M, Bergesio F, Cappelli F, Chiappini MG, et al
    Is Hereditary Transthyretin Amyloidosis the Third Leading Cause of Monogenic Chronic Kidney Disease, Only Behind ADPKD and Alport Disease?
    Am J Nephrol. 2022 Nov 7:1-4. doi: 10.1159/000526955.

    J Nephrol

  5. DE JONGE E, van der Vooren M, Gillis JMEP, Del Prado MR, et al
    Negative calcium balance despite normal plasma ionized calcium concentrations during citrate anticoagulated continuous venovenous hemofiltration (CVVH) in ICU patients.
    J Nephrol. 2022 Nov 7. pii: 10.1007/s40620-022-01482.
    PubMed         Abstract available

  6. DUONG H, Tesfaye W, Van C, Sud K, et al
    Sick day management in people with chronic kidney disease: a scoping review.
    J Nephrol. 2022 Nov 3. pii: 10.1007/s40620-022-01497.
    PubMed         Abstract available

  7. GOMEZ-GARCIA EF, Del Campo FM, Cortes-Sanabria L, Mendoza-Carrera F, et al
    Transcription factor NRF2 as potential therapeutic target for preventing muscle wasting in aging chronic kidney disease patients.
    J Nephrol. 2022 Nov 2. pii: 10.1007/s40620-022-01484.
    PubMed         Abstract available

    Kidney Int

  8. MANN JFE, Joseph P, Gao P, Pais P, et al
    Effects of aspirin on cardiovascular outcomes in patients with chronic kidney disease.
    Kidney Int. 2022 Oct 27. pii: S0085-2538(22)00848.
    PubMed         Abstract available


  9. MARK PB, Sattar N
    Implementation, not hesitation, for SGLT2 inhibition as foundational therapy for chronic kidney disease.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)02164.

    N Engl J Med

  10. BHANDARI S, Mehta S, Khwaja A, Cleland JGF, et al
    Renin-Angiotensin System Inhibition in Advanced Chronic Kidney Disease.
    N Engl J Med. 2022 Nov 3. doi: 10.1056/NEJMoa2210639.
    PubMed         Abstract available

  11. HERRINGTON WG, Staplin N, Wanner C, Green JB, et al
    Empagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med. 2022 Nov 4. doi: 10.1056/NEJMoa2204233.
    PubMed         Abstract available

    Nephrol Dial Transplant

  12. MATHUR VS, Bushinsky DA, Inker L, Klaerner G, et al
    Design and Population of the VALOR-CKD Study: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating the Efficacy and Safety of Veverimer in Slowing Progression of Chronic Kidney Disease in Patients with Metabolic Acidosis.
    Nephrol Dial Transplant. 2022 Nov 4. pii: 6776172. doi: 10.1093.
    PubMed         Abstract available

  13. PORRINI E, Perez NM, Diaz JM, Lauzurrica R, et al
    Post-transplant diabetes mellitus and renal cell cancer after renal transplantation.
    Nephrol Dial Transplant. 2022 Nov 2. pii: 6794278. doi: 10.1093.
    PubMed         Abstract available

  14. GREINERT R, Greinert D, Eger AL, Ripoll C, et al
    Subclinical cognitive impairment in chronic kidney disease is associated with frailty and reduced quality of life.
    Nephrol Dial Transplant. 2022 Nov 2. pii: 6794277. doi: 10.1093.
    PubMed         Abstract available

  15. HUNDEMER GL, Ravani P, Sood MM, Zimmerman D, et al
    Social determinants of health and the transition from advanced chronic kidney disease to kidney failure.
    Nephrol Dial Transplant. 2022 Oct 31. pii: 6783171. doi: 10.1093.
    PubMed         Abstract available

    Pediatr Nephrol

  16. LIJDSMAN S, Oostrom KJ, van Sandwijk MS, Bouts AH, et al
    Risk factors for neurocognitive impairment and the relation with structural brain abnormality in children and young adults with severe chronic kidney disease.
    Pediatr Nephrol. 2022 Nov 2. pii: 10.1007/s00467-022-05781.
    PubMed         Abstract available

  17. KAMATH N, Iyengar A, Reddy HV, Sharma J, et al
    Changes in bone biomarkers in response to different dosing regimens of cholecalciferol supplementation in children with chronic kidney disease.
    Pediatr Nephrol. 2022 Nov 2. pii: 10.1007/s00467-022-05790.
    PubMed         Abstract available

    PLoS One

  18. HUANG YT, Jiang MY, Hwang JC
    Albumin to prealbumin ratio in peritoneal dialysis patients: Clinical implication and outcome prediction.
    PLoS One. 2022;17:e0276159.
    PubMed         Abstract available

    Semin Dial

  19. PENG J, Lin H, Cai C, Cai C, et al
    New method of internal fixation in laparoscopic Tenckhoff catheter placement.
    Semin Dial. 2022;35:498-503.
    PubMed         Abstract available

    Transplant Proc

  20. NORRIS T, Montgomery R, Cibrik D, Reintjes M, et al
    Pretransplant Psoas Muscle Cross-Sectional Area and Postkidney Transplant Outcomes.
    Transplant Proc. 2022;54:1816-1821.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.